Qinlock

Active Ingredient(s): Ripretinib
FDA Approved: * May 15, 2020
Pharm Company: * DECIPHERA PHARMS
Category: Cancer

Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract.[2][3] It is taken by mouth.[2][3] Ripretinib inhibits the activity of the kinases KIT and PDGFRA, which helps keep cancer cells from growing.[3] The most common side effects include alopecia (hair loss), fatigu... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Qinlock 50 mg Oral Tablet
NDC: 73207-101
Labeler:
Decipera Pharmaceuticals, LLC